Reynolds Consumer Products Inc.
$6.04B- Market cap
- $4.61B
- Debt
- +$1.59B
- Cash
- −$147.00M
Capital structure 74% equity / 26% debt · EV / Revenue 1.62x · EV / EBITDA 10.40x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: REYN stock price near parity vs PAHC $21.85 current versus $22.51 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at PAHC's multiple
Implied fair value · at REYN's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Multiple discount
Value edge
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: REYN FY 2025 (ended Dec 31, 2025) · PAHC FY 2026 (ended Jun 30, 2026). Fiscal years are not aligned.
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 74% equity / 26% debt · EV / Revenue 1.62x · EV / EBITDA 10.40x
Capital structure 73% equity / 27% debt · EV / Revenue 2.31x · EV / EBITDA 15.03x
REYN carries the larger enterprise value at $6.04B against $3.51B; REYN trades on the lower EV / Revenue multiple (1.62x vs 2.31x); REYN on the lower EV / EBITDA (10.40x vs 15.03x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
REYNOLDS CONSUMER PRODUCTS INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Phibro Animal Health Corporation · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.70x
2.47x
Net debt / EBITDA
Leverage against operating earnings
2.48x
3.73x
Cash and equivalents
Liquid reserves on the balance sheet
$147.00M
$81.99M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
BALL Corp
REYN vs BALL
GRAPHIC PACKAGING HOLDING CO
REYN vs GPK
SEALED AIR CORP/DE
REYN vs SEE
CLOROX CO /DE/
REYN vs CLX
Avery Dennison Corp
REYN vs AVY
SONOCO PRODUCTS CO
REYN vs SON
Zoetis Inc.
REYN vs ZTS
Elanco Animal Health Inc
REYN vs ELAN
Merck & Co., Inc.
REYN vs MRK
Viatris Inc
REYN vs VTRS
HARROW, INC.
REYN vs HROW
$1.59B
$951.75M
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.